BS

Bhopal Singh Saini

Active Director Designated Partner DIN 11700463
DIN 11700463 First appointment May 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Bhopal Singh Saini

Data last updated:

Bhopal Singh Saini is a Designated Partner at Medwin Super Speciality Hospital Llp (since 2026).

DIN 11700463
Primary Designation Designated Partner
First Appointment 05 May 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner05 May 20262026Active

Board colleagues of Bhopal Singh Saini

NameDINCompanyDesignation
Gautam Singh11700464Medwin Super Speciality Hospital LlpDesignated Partner
Monika Govind Rao09859901Medwin Super Speciality Hospital LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Medwin Super Speciality Hospital Llp
Premium access

Shareholding and investment profile for Bhopal Singh Saini

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Bhopal Singh Saini

Bhopal Singh Saini currently holds 1 directorship: Medwin Super Speciality Hospital Llp (Designated Partner, since 05 May 2026).

Bhopal Singh Saini was first appointed on 05 May 2026 as Designated Partner at Medwin Super Speciality Hospital Llp.

The current boards of Bhopal Singh Saini's companies include Gautam Singh (Medwin Super Speciality Hospital Llp), Monika Govind Rao (Medwin Super Speciality Hospital Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available